Checkpoint Capital L.P. Portfolio Holdings

Checkpoint Capital L.P. has filed its 13F form on November 14, 2024 for Q3 2024 where it was disclosed a total value porftolio of $202 Billion distributed in 16 stocks.

Among their holdings, we can observe that their the top five positions include companies like: Argenx Se with a value of $50.1B, Rhythm Pharmaceuticals, Inc. with a value of $34.8B, Phathom Pharmaceuticals, Inc. with a value of $27.2B, Cytokinetics Inc with a value of $24.6B, and Axsome Therapeutics, Inc. with a value of $18.8B.

Examining the 13F form we can see an increase of $35.7B in the current position value, from $166B to 202B.

Checkpoint Capital L.P. is based out at San Francisco, CA

Below you can find more details about Checkpoint Capital L.P. portfolio as well as his latest detailed transactions.